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INTRODUCTION
The microemulsion (MEs) concept was introduced as are molecularly 
dispersed. Most of the researchers in 1940’s who generated a clear 
single-phase solution by Titratinga milky emulsion with hexanol. 
Schulman et al. (1959) subsequently coined the term ME [1,2].
The MEs definition provided by Danielson and Lindman in 1981 will be 
used as the point of reference.
These systems have an advantage over “conventional emulsions” 
is that they are thermodynamically stable liquid systems and are 
spontaneously self-forming. Moreover, the radius of MEs is as small as 
<100 nm, which indicates that the nanoscale effect of MEs will enhance 
either the penetration into or absorption by cells. To develop MEs 
(MEs), an important parameter take into account is the hydrophilic-
lipophilic balance (HLB) of the surfactant or surfactant mixture. It 
is related to the contribution of both hydrophilic and hydrophobic 
fragments of a surfactant molecule. In general, surfactants with HLB 
values between 8 and 20 are able to form O/W MEs, while W/O MEs are 
formed when the HLB range is 4-7 [3,4].
It is also known that using mixed surfactants or adding can reduce the 
surface tension between oil and water when preparing ME. Choice of the 
surfactant is critical for the formulation of MEs. The HLB of surfactant 
may be adjusted by a short-chain alcohol, or adding either a non-ionic 
surfactant for the preparation of stable MEs is known that a single 
surfactant is not sufficient to form single-phase MEs and an adequate 
mixture of surfactants may be required to optimize the MEs formation.
The use of mixtures of nonionic surfactants is an interesting approach 
from the pharmaceutical point of view since such surfactants are 
generally regarded as low toxicity and irritancy and therefore, 
considered to be acceptable for oral administration. In addition, the 
use of mixtures allows the individual concentration of each surfactant 
to be decreased, which may increase the biocompatibility of the final 
formulations. Therefore, Tween80 was mixed with the hydrophobic 
surfactants of the Span series to provide surfactant blends to screen 
and select the best surfactant mixture to prepare oil-in-water (o/w) 
MEs [5,6].
Injectable emulsions must meet many of the same requirements 
that pertain to all parenteral products. These requirements include 
physicochemical stability (physically and chemically stable), endotoxin 
free, sterilizable, maximum globule size (<1 or 2 mm), and biological 
stability (low incidence of side-effects, sterile and non-antigenic and all 
components metabolized or excreted).
Unique to parenteral emulsions are strict requirements for globule size 
and surface charge. These two aspects are important in the manufacture 
and control of emulsions.
All injectable emulsions are their strict globule size requirement, as this 
has a direct effect on both toxicity and stability [7,8].
Advantages of MEs over other dosage forms
1. Increase the rate of absorption
2. Eliminates variability in absorption
3. Helps solubilize lipophilic drug
4. Provides an aqueous dosage form for water insoluble drugs
5. Increases bioavailability
6. Various routes such as tropical, oral, and intravenous can be used to 
deliver the product
7.	 Rapid	and	efficient	penetration	of	the	drug	moiety
8. Helpful in taste masking
9. Provides protection from hydrolysis and oxidation as a drug in oil 
phase in o/w ME is not exposed to attack by water and air
10. Liquid dosage form increases patient compliance
11. Less amount of energy requirement.
PARENTERAL DELIVERY
MEs are commercially feasible, simple and convenient novel vehicles 
for delivery of medicaments which can enhance drug absorption with 
reduced systemic side effects. They can be used to optimize drug 
targeting without a concomitant increase in systemic absorption. 
Appropriate excipient selection and safety evaluation especially of the 
co-surfactants crucial in the formulation of MEs. They can be potential 
drug delivery systems for the delivery of more than one medicament 
simultaneously [9].
O/w emulsions are currently employed as safe and efficacious vaccine 
adjuvant in various vaccine products already approved for human use 
or in clinical trials. The leading o/w emulsions developed for vaccine 
applications, such as MF59 and AS03, are squalene-based (AS03 also 
contains - tocopherol).
The formulation of lipophilic and hydrophobic drugs into parenteral 
dosage forms has proven to be difficult. O/w MEs are beneficial in the 
parenteral delivery of sparingly soluble drugs where the administration 
of suspension is not desirable. They provide a means of obtaining 
relatively high concentration of these drugs which usually requires 
frequent administration. Other advantages are that they exhibit a 
more physical stability in plasma than liposomes or other vesicles and 
the internal oil phase is more resistant against drug leaching. Several 
Review Article
Department of Pharmaceutics, Raja Bahadur Venkata Rama Reddy Women’s College of Pharmacy, Hyderabad, Telangana, India. 
Email: shailaja1234@rediffmail.com
Microemulsions (MEs) have attracted much interest over the past years as potential drug delivery systems because of their transparency ease of in 
preparation and long-term stability. MEs provide sustained or controlled drug release for different routes of administration including parenteral 
administration. It shows advantages in the drug delivery like greater absorption of drugs, alteration of the kinetics of the drug release and decreased 
toxicity are several advantages in the delivery process. In this article, the ME preparation techniques and applications were discussed in detail.
Received: 25 Jenuary 2016, Revised and Accepted: 23 Febuary 2016
                      ABSTRACT
Vol 4, Issue 2, 2016 ISSN - 2321-550X
2
sparingly soluble drugs have been formulated into o/w ME for parenteral 
delivery MEs can also be used as intravenous delivery systems for the 
fat soluble vitamins and lipids in parenteral nutrition [10].
Advantages of parenteral emulsions
•	 The	MEs	 have	 the	 advantage	 of	 a	 very	 small	 dispersed-phase	
diameter, which can impart thermodynamic stability. For many drugs, 
insufficient	aqueous	solubility	and/or	water	hydrolysis	are	the	major	
formulation challenges. By incorporating the drug in the interior 
oil phase, these problems can be reduced. Use of conventional co-
solvent systems can be avoided as well as the associated undesirable 
effects caused by precipitation of the drug at the injection site. 
Moreover, protein binding and hydrolytic degradation of drugs such 
as barbiturates12 do not occur as long as the drug remains in the oil 
phase, thus further contributing to an improved therapeutic index for 
emulsion formulations compared with aqueous solutions. While in 
many cases incorporation of a drug into the oil phase of an emulsion 
might	not	 reduce	 the	hydrolysis	 rate	 sufficiently	 to	permit	 the	
development of a liquid product that is stable at room temperature.
•	 Another	advantage	of	parenteral	emulsions	is	the	potential	to	provide	
for sustained release. Delayed absorption for the drugs with the 
large	partition	coefficient	can	be	achieved	using	MEs.	The	phase	
volume ratio between the lipid and aqueous phases in the delivery 
system decides the fraction of the drug available for the absorption. 
For example, if the volume of the aqueous phase is much larger 
than	that	of	the	oil	phase,	a	large	partition	coefficient	will	result	in	a	
small fraction of the drug being available for absorption and hence 
a sustained release effect [11] (Tables 1-3).
THEORIES OF ME FORMATION
Various theories concerning ME formulation, stability and phase 
behavior have been proposed over the years. For example, one 
explanation for their thermodynamics stability is that the o/w 
dispersion is stabilized by the surfactant present and their formation 
involve the elastics properties of the surfactant films at the o/w 
interface, which involves, the curvature and the rigidity of the film. 
These parameters may have pressure and temperature dependence 
(the salinity of the aqueous phase). Which may be used to infer the 
region of stability of the ME, or to delineate the region where three 
coexisting phase occur [13,14].
Phase behavior
The first unifying classification of the phase behavior accounting for 
the different phenomena observed in ternary oil-water-amphiphile 
Table 1: Potential micro emulsion systems for drug of varying physicochemical and biological properties





Aqueous solution Organic solution
+++ + + w/o Protection against enzymatic and hydrolytic degradation
Enhanced bioavailability
+++ +++ +++ w/o or o/w Protection against enzymatic and hydrolytic degradation
+ +++ + o/w Improved solubilization and rate of solution
+ +++ +++ o/w Improved solubilization and rate of solution
+++: High, +: Low,  w/o: water- in-oil, o/w: oil-in-water
Table 2: Components available for parenteral microemulsions [12]
General class Examples Commercial name
Polysorbates POE-20-sorbitan monooleate
POE-20-sorbitanmonolaurate
Tween 80, chrillet 4
Tween 20, chrillet 1
Sorbitan esters Sorbitan mono laurate Span 20, chrill 1
PEO-PPO-Block co-polymers Poloxamer 188 Pluronic/lutrol F68
POE alkyl ethers POE-10-oleyl ether Brij 96 V
POE castor oil POE-35-castor oil Cremphor EL, Etocs 35 HV
POE hydrogenated castor oil POE-40-hydrogenated castor oil
POE-60-hydrogenated castor oil
Cremphor RH 40, HCO-40, Croduret 40 LD
Cremphor RH 60, HCO-60






Di myristoyl phosphatidyl choline
Fixed oils Soyabean oil, castor oil
MCT’s Triglycerides of capric/caprylic acid Miglylol 810, 812, labrafac CC Croadamol GTCC, Captacs 300, 355





Short chain alcohols Ethanol, benzyl alcohol
Alkane diols and triols PG
Glycerol
PEG PEG 400
Glycol ethers Tetrahydrofurfuryl PEG ether (tetra 
glycol or glycofurol)




Bile salts Sodium deoxycholate
Applications in veterinary products only, PG: Propylene glycol, PEG: Polyethylene glycols, IPP: Isopropyl palmitate, IPM: Isopropyl myristate
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system was published by Winsor in 1948. On the basis of an extensive 
experimental study of different mixtures, Winsor distinguishes among 
four general type of phase behavior, schematically represented (Fig. 1).
One phase system
Winsor IV: These mixtures can be water (S1) or oil dispersible (S2), or 
gel (G) or a mixture of G with S1 or S2, respectively.
Two phase system
Winsor I: (Direct) micelles in water in equilibrium with an oil phase.
Winsor II: Reverse micelles in oil in equilibrium with an aqueous phase.
Three phase system
Winsor III: Most of the surfactant in a middle phase is in equilibrium 
with an upper organic phase and a lower aqueous phase. The middle 
phase may also be water - oil - dispersible.
Even though some particular system exhibits a phase behavior that 
is not accounted for classified in Winsor classification, it remains an 
important tool for the description of amphiphillic aggregation in multi-
component systems.
ME FORMULATION DEVELOPMENT [15]
Much of the interest in the use of MEs as vehicles arises from their 
unique physical properties, in particular their thermodynamic stability 
and ease of preparation, Although this interest has recently been further 
stimulated by the introduction, in Europe and America by Sandoz (Basel, 
Switzerland), of a very successful oral ME pre-concentrate formulation 
of cyclosporine called Neoral. MEs, has been extensively studied in the 
pharmaceutical sciences as a means of enhancing the solubility and 
controlling the delivery of protein and peptide drugs.
MEs are defined as systems which comprise of a mixture of 
water, hydrocarbons and amphiphilic compounds which form 
thermodynamically stable, homogeneous (heterogeneous at molecular 
scale), optically isotropic solutions.
METHOD OF PREPARATION OF ME
Phase titration method
MEs are prepared by the spontaneous emulsification method (phase 
titration method) and it is depicted with the help of phase diagram. 
Construction of phase diagram is studied by complex series of 
interaction occurred by different components mixture. A quaternary 
phase diagram (four component system) is time-consuming and 
difficult to interpret, pseudo ternary phase diagram is often constructed 
to fine the different zones including MEs zone, in which each corner of 
the diagram represents 100% of the particular component [8]. Gibbs 
phase diagrams can be used to show the influence of changes in the 
volume fractions of the different phases on the phase behavior of the 
system.
Phase inversion method
Phase inversion of MEs is carried out on addition of excess of the 
dispersed phase or in response to temperature. During phase inversion, 
drastic physical changes occur including changes in particle size that 
can ultimately affect drug release both in vitro and in vivo [10]. These 
methods make use of changing the spontaneous curvature of the 
surfactant. For non-ionic surfactants, this can be achieved by changing 
the temperature of the system, forcing a transition from an o/w ME at 
low temperatures to a w/o ME at higher temperatures (transitional 
phase inversion).
Preparation of ME
The drug is dissolved in the hydrophilic part of ME. Oil and the water 
phases can be combined with a surfactant is then added at slow rate with 
gradual stirring until the system is formed. The amount of surfactant 
to be added and the percent of oil phase that can be incorporated 
shall be determined with the help of pseudo-ternary phase diagram. 
Homogenization and micro fluidizer ultra-sonication can finally be 
used to achieve the desired size range for dispersed globules.
Construction of phase diagram
Pseudo-ternary phase diagram of oil, water and surfactant mixture are 
constructed at fixed surfactant ration. Phase diagram is obtained by 
mixing of the ingredients which shall be pre-weighed into glass vial and 
titrated with water and stirred well at room temperature. Formulation 
of monophonic/biphasic system is confirmed by visual inspection. 
In case turbidity appears by a phase separation then the sample is 
considered as biphasic. In case, monophonic mixture is visualized by 
stirring then the sample is marked as a point in phase diagram. The area 
covered by the point is considered as the ME region.
COMPONENTS OF ME
Oil phase
The selection of oil mainly depends on the drug solubility. It will 
minimize the volume of the formulation to deliver the therapeutic dose 
of the drug in an encapsulated form. Oil having maximum solubilizing 
potential for the drug is selected for the formulation of the ME to 
achieve maximal drug loading. Oils with long hydrocarbon chains (or 
high molecular volume) such as olive, peanut, soybean, canola, and 
sunflower are difficult to micro emulsify, whereas oils with shorter 
(or low molecular volume) such as medium chain triglycerides, 
medium chain mono- and diglycerides are easier to micro emulsify. The 
capacity of solubilizing lipophilic moieties usually increases with the 
chain length of the oil.
Oils mainly used for the formulation of ME are as follows:
1. Saturated fatty acid-lauric acid, myristic acid, capric acid
2. Unsaturated fatty acid-oleic acid, linoleic acid, linolenic acid
3. Fatty acid ester-ethyl or methyl esters of lauric, myristic and oleic 
acid.
The oil component influences curvature by its ability to penetrate and 
hence swell the tail group region of the surfactant monolayer. Short 
chain oils have better-penetrating efficiency to the tail group region 
than long chain alkenes, and hence, swell this region to a greater extent, 
resulting in increased negative curvature (and reduced effective HLB). 
Saturated (for example, lauric, myristic and capric acid) and unsaturated 
fatty acids (for example, oleic acid, linoleic acid and linolenic acid) have 
penetration enhancing a property of their own and they have been 
studied since a long time. Fatty acid esters such as ethyl or methyl 
esters of lauric, myristic and oleic acid have also been employed as the 
oil phase [1]. Lipophilic drugs are preferably solubilized in o/w MEs 
(Fig. 2).
Note the greater the extent of oil penetration when the film curves 
toward water (i.e. the region of reserve curvature).
Table 3: Some marketed products in parenterals
Drug name Route Purpose/result
Flurbiprofen Parenteral Increased the solubility
Itraconazole Parenteral For better absorption
Fig. 1: Phase behavior in accordance with Winsor system
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Depending on the nature of the oil, in particular, its size relative to the 
hydrophobic chain of the surfactant, the oil may penetrate to varying 
extents into the surfactant tails of the interfacial monolayer. For a 
bicontinuous ME a similar effect has been proposed to occur in both 
o/w and w/o ME.
Aqueous phase
The aqueous phase, in practice, is almost never just water because 
most formulations dictate the use of several additives such as buffers, 
isotonic agents, antibacterial compounds, and many others that might 
in some cases affect the ME. Salinity might strongly affect MEs made of 
anionic surfactants. Low pH might also damage the ME, mainly if esters 
of fatty acids are used as surfactants and/or oils, and, therefore, it is 
always recommended to keep the ME as close as possible to neutral pH.
The aqueous phase should be augmented by incorporation of ionic or 
osmotic agents, antioxidants, buffers and preservatives as required. 
Because emulsified oil exerts no osmotic effect, isotonic adjustment 
(to 280-300 mosm/kg) will be important for large-volume parenterals 
such as the injectable fat emulsions. Glycerol has been preferred by 
the manufacturers of soybean oil emulsion. In addition to contribution 
to tonicity, glycerol in combination with propylene glycol has been 
shown to reduce the globule size and improve the creaming stability 
of o/w emulsions. Ionic agents (sodium chloride) and reducing sugars 
(glucose) should be avoided because of the potential interaction 
between reducing sugars and protein contaminants which results in 
brown discolouration and/or phase separation of the emulsion.
Surfactants
Surfactants belong to a group of substances that meet certain 
characteristics like: Good surface activity, are able to form condensed 
interfacial films and their diffusion rates to interface are comparable 
to emulsion forming time. According to their structure, surfactants are 
classified in:
1. Anionic (e.g. sodium stearate, potassium laurate, alkyl sulfates like 
sodium dodecyl sulfate, and sodium sulfosuccinate).
2. Nonionic (nonylphenol with ethylene oxide units, poly glycol, fatty 
acid esters, and lecithin).
3. Cationic (quaternary ammonium salts and amine hydrochlorides); 
zwitter ionic/amphoteric (amino acids, phospholipids, and 
derivatives of quaternary ammonium compounds) or polymeric and 
silicone surfactants which could be either of the above.
A surfactant is chosen for a certain application mostly by trial and error, 
although the best way is to learn how to use HLB value which only 
applies to nonionic surfactants.
Each oily material requires a different strength of emulsifier to ensure 
the stability of its emulsion. This is referred to as the HLB requirement 
for that oil. Vegetable oils are the easiest to emulsify, mineral oils are 
moderately difficult while silicone oils are the most difficult to stabilize. 
Matching HLB and the chemical structure of oil and emulsifying agent 
is an ideal situation. Such information, however, is only available for a 
limited number of compounds. Blending surfactants (by varying their 
composition in the mixture) also allow the selection of an optimum HLB 
for a given application.
Based on the Bancroft’s rule, it is possible to change or invert an 
emulsion from o/w type to w/o type by inducing changes in surfactant 
HLB and critical packing parameter (CPP) values. Making the emulsifier 
more oil soluble tends to produce a w/o emulsion and vice versa.
This is accomplished by:
i. Altering the order of the addition of the phases (e.g. adding water 
to	oil	and	emulsifier	will	produce	a	W/O	emulsion,	while	adding	oil	
to	water	and	emulsifier,	an	O/W	emulsion	is	obtained).
ii. Variations in the phase volume ratio (e.g. if the o/w ratio is increased, 
an w/o emulsion is obtained, and vice versa).
iii. Temperature variations and the presence of electrolytes and other 
additives like alcohols, disrupt the water molecules around nonionic 
and ionic surfactants, respectively, altering surfactant solubility and, 
therefore, inducing inversion (e.g. increasing the temperature of an 
o/w emulsion, makes the nonionic surfactant more hydrophobic and 
the emulsion could invert to w/o).
Emulsion inversion is particularly useful when the final emulsion 
is subjected to specifications that are not attainable with more 
conventional emulsification methods, as for instance in the case of tiny 
droplets of very viscous oils.
Surfactants facilitate emulsification by reducing interfacial tension 
and stabilization by introducing double layer forces and/or solvation 
forces between dispersed particles. Such solution-like systems form 
spontaneously when the components are brought together in a proper 
ratio and when the interfacial tension is around 10−3 mN m−1.
Optimization of process variables of ME [16]
Preparation of ME involves various process variables, out of which the 
followings were selected:
a. Effect of the oil concentration
b. Effect of co-surfactant concentration
c. Effect of type of oil.
Optimizations by selective parameters or experimental designs allow 
to conclude that, with respect to composition variables, generally 
there is an optimum surfactant mixture composition, or HLB, and that 
the higher the oil surfactant ratio the greater the droplet size. The 
preparation variables, like addition, agitation or cooling rate, generally 
do not have a significant influence if the system is optimized with 
respect to composition.
CHARACTERIZATION
Characterization of ME requires macro analytical tools, such as viscosity, 
conductivity, dielectric, differential scanning calorimetry, together 
with scattering advanced techniques (dynamic light scattering [DLS], 
small-angle X-ray scattering [SAXS], small-angle neutron scattering 
[SANS]) and spectroscopic advanced methods (high resolution-nuclear 
magnetic resonance [NMR], PSEG-NMR) and electronic microscopy 
(transmission electron microscopy [TEM] and cryo-TEM). Some of 
the major methods relevant to the characterization of the MEs include 
viscosity and conductivity measurements as well as more advanced 
methods such as pulsed gradient spin echo (self-diffusion) NMR. Other 
sophisticated methods such as time corrected single-photon counting 
methods (photo physics of a fluorescent drug) have also been utilized.
The commonly used techniques for structural information are SANS, 
SAXS and DLS.
Stability studies of the emulsion
•	 Physical	examination:	Visual	observation	for	creaming,	coalescence,	
oil separation, and color change
•	 Chemical	analysis:	Determination	and	characterization	of	the	drug	
Fig. 2: Penetration of oil molecules between the hydrophobic 
chains of the interfacial surfactant monolayer in a bicontinuous 
micro emulsions
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substance,	 oil,	 emulsifier(s)	 and	 adjuvant’s	 present,	 as	well	 as	
degradation of related substances, including, in particular, free fatty 








Shelf-life stability of MEs, both as a function of time and storage 
temperature was routinely evaluated by visual inspection of the 
samples initially on a daily and later on a weekly basis. Stable systems 
were identified as those free of any physical change, such as, phase 
separation, flocculation, and/or precipitation. The particle size of 
the MEs upon storage was also determined to assess ME stability in 
terms of drastic changes in the mean droplet diameter due to droplet 
coalescence and/or aggregation. Stability was monitored at 4°C, 
ambient temperature, 37 and 50°C [17].
The small droplets adhere to membranes at a greater extent as well as 
transport bioactive molecules in a more controlled fashion. Using the 
ME vehicles, water-insoluble and oil-soluble components from different 
plant extracts can be co-solubilized to attain synergistic effect for a 
specific therapeutic goal.
CONCLUSIONS
MEs can be considered as an effective vehicle for the solubilization of 
certain drugs and as protecting medium for the entrapped of drugs from 
degradation, hydrolysis, and oxidation. MEs provide prolonged release 
of the drug and prevent irritation despite the toxicity of the drug.
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